Key facts
- This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 17:56.
Timothy Wright - 15 Jun 2021 Form 4 Insider Report for AGENUS INC (AGEN)
- Reporting relationship
- Director
- Issuer ticker
- AGEN
- Reported as of
- 15 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 17:56:53 UTC
- Next SEC filing
- 21 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/Adam Krauss, as Attorney-in-Fact for Timothy R. Wright
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 02 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGEN
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 15 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $3.18
- Footnotes
- F1
AGEN
transaction
Derivative
Deferred Stock Units
Award
- Transaction value
- Shares
- +2,454
- Change %
- +1.9%
- Price
- Shares after
- 130,928
- Date
- 01 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,454
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022.
Footnote F2
Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
Footnote F3
Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
Footnote F4
$3.820 per Deferred Stock Unit acquired on July 1, 2021. The price of each Deferred Stock Unit acquired prior to July 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan